1 Min Read
May 19 (Reuters) - VIFOR PHARMA LTD (IPO-VIFP.S):
* CHMP RECOMMENDS VELTASSA FOR TREATMENT OF HYPERKALAEMIA IN EU
* FINAL EU COMMISSION DECISION EXPECTED IN Q3 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.